Efficacy of Stellate Ganglion Block in Patients With Parkinson's Disease

Last updated: March 2, 2024
Sponsor: People's Hospital of Zhengzhou University
Overall Status: Trial Not Available

Phase

N/A

Condition

N/A

Treatment

Rehabilitation therapy

Stellate ganglion block

Clinical Study ID

NCT06206538
2024-KY-0103-003
  • Ages > 18
  • All Genders

Study Summary

The goal of this or clinical trial is to explore efficacy of stellate ganglion block on dysphagia and activities of daily living in patients with Parkinson's disease. The main question it aims to answer are:

• Can stellate ganglion block improve the dysphagia and activities of daily living in patients with Parkinson's disease.

Participants will be divided into the the control group and observation group evenly. All the patients were provided with routine therapy, while the patients in the observation group were given stellate ganglion block. The swallowing function, and activities of daily living of the two groups of patients before and after treatment were evaluated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age >18 years.
  • Meeting the diagnostic criteria for Parkinson's disease developed by the NeurologyBranch of the Chinese Medical Association in 2006.
  • Diagnosed with dysphagia confirmed by the video fluoroscopic swallowing study.
  • Stable vital signs, conscious, able to cooperate with assessment and treatment.

Exclusion

Exclusion Criteria:

  • Dysphagia possibly caused by other reasons, such as cerebrovascular disease, trauma,neuromuscular diseases, malignant diseases of the pharynx and larynx, and digestivetract diseases.
  • History of mental diseases or use of antipsychotics.
  • Complicated with cognitive impairment or consciousness dysfunction.
  • Simultaneously suffering from severe liver, kidney failure, tumors, or hematologicaldiseases.

Study Design

Treatment Group(s): 2
Primary Treatment: Rehabilitation therapy
Phase:
Study Start date:
January 15, 2024
Estimated Completion Date:
April 10, 2024

Study Description

Dysphagia, or swallowing difficulty, is a common symptom associated with Parkinson's disease. It is characterized by weakened chewing and throat muscles, leading to difficulties in eating, coughing, and a sensation of choking in individuals with Parkinson's disease.

The goal of this or clinical trial is to explore efficacy of stellate ganglion block on dysphagia and activities of daily living in patients with Parkinson's disease. The main question it aims to answer are:

• Can stellate ganglion block improve the dysphagia and activities of daily living in patients with Parkinson's disease.

Participants will be divided into the the control group and observation group evenly. All the patients were provided with routine therapy, while the patients in the observation group were given stellate ganglion block. The swallowing function, and activities of daily living of the two groups of patients before and after treatment were evaluated.

Connect with a study center

  • Peking University Sixth Hospital

    Beijing, Beijing 101499
    China

    Site Not Available

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan 450000
    China

    Site Not Available

  • Zheng Da Second Yuan Hospital

    Zhengzhou, Henan 450000
    China

    Site Not Available

  • Zheng Da yi Yuan Hospital

    Zhengzhou, Henan 450000
    China

    Site Not Available

  • Mianyang Central Hospital

    Mianyang, Sichuan 621000
    China

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.